Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

SAN FRANCISCO, CA / ACCESSWIRE / January 14, 2025 / Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) faces a securities fraud ...

During my visit to CES 2025, I sought out a pair of special smart glasses that could give me hope for my son's future.

In this video, Clement K. Chan, MD, FACS, discusses a presentation from the AAO meeting on multimodal imaging to assess geographic atrophy.In a session on diagnostic techniques for identifying and ...

Regeneron Pharmaceuticals, Inc. REGN provided business and pipeline updates at the 43rd Annual J.P. Morgan Healthcare ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, ...

A recent retrospective cohort study unveiled a crucial connection between obstructive sleep apnea (OSA) and an increased risk ...

Ian Wilson, Managing Director and car insurance expert at Tiger.co.uk, has warned that motorists may be taking risks by ...

After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company ...

The family and friends of the late MRS MAUREEN SHAY HEARL are advised that her Funeral Service will be conducted in its ...

(NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to redefining the retina experience, outlined exceptional clinical progress across its registrational program for AXPAXLI ...